Recombinant Human C19orf40 Protein，GST

C19orf40, also known as Caspase-activated Protein 1 (CAP1), is a protein that has garnered significant interest in recent years due to its potential roles in cellular processes such as apoptosis and cell proliferation. Research indicates that C19orf40 may be involved in various physiological and pathological conditions, including cancer and neurodegenerative diseases. The gene encoding this protein is located on chromosome 19, and its expression has been associated with the regulation of caspase activity, playing a crucial role in programmed cell death. Given the importance of apoptosis in maintaining cellular homeostasis and its implications in disease, the study of C19orf40 as a recombinant protein has become a focal point of investigation. Scientists aim to elucidate its structure, functional mechanisms, and interactions with other cellular components, which are essential for several biological pathways. Furthermore, the development of recombinant C19orf40 allows for the exploration of its potential as a biomarker and therapeutic target, particularly in cancer research, where dysregulation of apoptotic pathways is prevalent. By generating recombinant forms of this protein, researchers can conduct functional assays, high-throughput screening, and structural studies to better understand its biological significance and therapeutic potential. Overall, the exploration of C19orf40 as a recombinant protein embodies a promising avenue for advancing our understanding of cell death mechanisms and their relevance to human health and disease.